Thanks mate. Pleasure meeting you.All good from my perspective...

First 4 Last

Share
Profile

Follow
peto2810

1,566 Posts.

514

26/05/23

19:53

Post #: 67988911
Share

Originally posted by keith54: ↑

hi all , I thought I would share my thoughts on todays general meeting held today in perth . First of all a shout out to Dan and Peto and also Chris who hold a quadrillion shares lol (top 5) , was great to finally meet some of the big boys and both myself and lonewolfe (Paul) appreciated our chat . So my last post had a few concerns re the lack of news / direction and what progress BRK had made with any sort of a monetisation situation. Well after today am very happy at where things are at , thank you David prentice , a great presentation and thanks for answering all concerns. To sum it up as my understanding is we have a great location of land with two good wells in one area producing at the lower end of the acreage , continental is doing a 12 well horizontal project directly under our DSU . So why BRK have not announced a direction is because they are waiting to see how good this project turns out as to what direction they head . There originally plan of 20 wells over 5 years could be done a lot quicker if BRK venture down that path , 12/14 horizontal wells at once . Now if continental want to repeat this project and go again we'll the best oil and gas is north which means they have to go through BRK meaning maybe a possible joint venture . Now with there current reserves when oil was 95.00 a barrel made sense to drill wells full steam ahead as quicker return , oil has dropped therefore this horizontal 12 wells project which is quicker and cheaper way makes sense , so waiting on the out come of continentals project makes total sense to me now . I guess with the reserves we have it's like having 100 million in a term deposit ....5 % return is a lot better than 3% . In summary, was really glad I went and believe the next 6months will be big , David believes oil will go up as the world supplies have been depleted and will need to be restocked so demand will be there . So all in all happy as they have been in talks with numerous companies and are really committed on returning best out come for shareholders, I hope this post gives a little more understanding and apologies as not as detailed as Dan pec lol
Take care all

Expand

Thanks mate. Pleasure meeting you.

All good from my perspective

Keep well cheers Paul

BRK Price at posting: 1.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 14 more messages in this thread...

First 4 Last

Add BRK (ASX) to my watchlist

(20min delay)
Last 1.0¢		Change 0.000(0.00%)		Mkt cap ! $47.72M

Open	High	Low	Value	Volume
1.0¢	1.0¢	0.9¢	$60.59K	6.304M

Buyers (Bids)

No.	Vol.	Price($)
42	26012193	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	14288886	16

View Market Depth

No.	Vol.	Price($)
41	25967193	0.009
26	17785321	0.008
9	4326571	0.007
5	2255009	0.006
7	2758000	0.005

Price($)	Vol.	No.
0.010	14288886	16
0.011	50033158	47
0.012	11460109	19
0.013	16597673	16
0.014	11908750	14

Last trade - 16.10pm 07/10/2024 (20 minute delay)

BRK (ASX) Chart

Thanks mate. Pleasure meeting you.All good from my perspective...

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks mate. Pleasure meeting you.All good from my perspective...

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News